Revenue surges, profit implodes—the margin lag will define FY'27

On the surface, a revenue print of ₹4,318 crore at 22.3% YoY looks robust. Dig into profit, and the quarter fractures. Consolidated PAT of ₹4 crore is not a typo — it's the net effect of stand-alone profit of ₹98 crore, erased by a ₹48-crore forex loss (CAMSO subsidiary LKR depreciation) and CAMSO's negative operating margins during its customer-transition phase. Even the stand-alone number tells a hard story: down 27% quarter-on-quarter despite revenue up 2.3% QoQ. This is a margin tale, not a growth tale.

Consolidated profit of ₹4 crore masks a real operational issue: stand-alone PAT of ₹98 crore still declined quarter-on-quarter. The gap comes from two forces. First, the Sri Lanka subsidiary's LKR depreciated from ₹310–315/$1 to ₹335/$1, triggering a ₹48-crore mark-to-market loss on an $80-million parent loan — this is non-cash but dents consolidated earnings. Second, CAMSO carries negative EBITDA in Q1 as it ramps transition costs (warehouses, hiring, new offices in Germany, UK, France, Poland) ahead of revenue realization; only 60% of customer handover is complete. The operating margin on stand-alone CEAT fell to 9.1% from prior 10%+ levels, and gross margin compressed 575 basis points to 33.9%, signaling raw material cost is still running ahead of price realization.

CAMSO margin trajectory downgraded. Prior FY'26 calls guided to ₹1,000–1,200 crore revenue with 12–13% margin by FY'28. The Q1 reality: negative EBITDA, 60% transition done, and recovery deferred to H2 FY'27 onward with no new margin target. This is an implicit downgrade, though management framed it as 'part of the plan; we will know more post-transition.' New capex for 2-wheeler capacity announced. Board approved a ₹1,205-crore capex for 53,000 additional 2-wheeler-tyre capacity, phased through FY'31. This sits within the existing ₹1,300–1,400 crore FY'27 capex envelope, so no fresh ask, but it signals capital intensity remains high and benefits are multi-year. Q2 margin pressure explicitly flagged. Management reiterated 'supportive but moderating' demand for FY'27, but openly flagged that Q2 margin pressure will persist—8–10% more raw material cost expected in Q2. This is rare transparency on a negative; the company is preparing street for another difficult quarter. Price hike quantum upgraded. Early signals were 'up to 10%' in cumulative hikes. The Q1 call disclosed 11% replacement hikes by early July, with a further 3–4% planned through August. Replacement segment is holding pricing so far, but demand elasticity remains an open question.

The market's reaction was swift and has held firm. The stock fell 7.3% on day 1 post-result, 11.01% by day 3, and 12.67% by day 5—a -₹224 move from the pre-result close of ₹3,829.6. At ₹3,605.4 as of this report, the selloff has stabilized but not reversed. The stock sits above its 50-day and 200-day moving averages (₹3,567 and ₹3,641 respectively) but 14% below its all-time high, signaling a re-rating rather than a panic. Notably, FII trimmed by 2.73 percentage points to 13.82%, while DII added 1.31 percentage points to 22.20%—foreign money is exiting, domestic money is buying weakness. This divergence suggests Indian institutions see value, but global money is waiting for margin recovery evidence.